Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A medicinal mushroom: Phellinus linteus.

Tongbo Zhu1, Sung-Hoon Kim, Chang-Yan Chen

  • 1Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Current Medicinal Chemistry
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.

Oncotarget·2015
Same author

A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.

British journal of pharmacology·2015
Same author

Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.

Bioorganic & medicinal chemistry letters·2015
Same author

Laparoendoscopic Single-site Compared With Conventional Laparoscopic Ovarian Cystectomy for Ovarian Endometrioma.

Journal of minimally invasive gynecology·2015
Same author

Meta-Analysis of Massage Therapy on Cancer Pain.

Integrative cancer therapies·2015
Same author

Apoptotic Effect of Galbanic Acid via Activation of Caspases and Inhibition of Mcl-1 in H460 Non-Small Lung Carcinoma Cells.

Phytotherapy research : PTR·2015
Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026
Same journal

Berberine as an Antimicrobial Agent and Gut Microbiota Modulator: Mechanisms and Therapeutic Potential.

Current medicinal chemistry·2026
Same journal

Research Progress of Grapefruit-derived Extracellular Vesicles in Anti-tumor Treatment.

Current medicinal chemistry·2026
Same journal

Corrigendum to: Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke.

Current medicinal chemistry·2026
Same journal

Ferroptosis and Its Crosstalk with Other Cell Death Modes in Ischemic Stroke.

Current medicinal chemistry·2026
Same journal

Integrative Analysis Reveals BPTF, COL1A1, and COL4A2 as Fibroblast-Related Biomarkers Associated with Immune Infiltration in Ovarian Cancer.

Current medicinal chemistry·2026
See all related articles

Phellinus Linteus (PL), a medicinal mushroom, shows promise in cancer treatment by stimulating the immune system and suppressing tumor growth. Research explores its potential as an alternative anticancer agent or a synergizer for chemotherapy.

Area of Science:

  • * Mycology
  • * Pharmacology
  • * Immunology
  • * Oncology

Background:

  • * Phellinus Linteus (PL) is a medicinal mushroom with a long history of use in traditional Eastern medicine.
  • * Extracts from PL have demonstrated immunomodulatory and anti-inflammatory properties.
  • * PL has shown potential in suppressing tumor growth and metastasis in various studies.

Purpose of the Study:

  • * To review the current understanding of Phellinus Linteus's anti-tumor mechanisms.
  • * To summarize research on PL's role in enhancing conventional chemotherapy.
  • * To introduce the identification of biologically active components within PL.

Main Methods:

  • * Review of existing scientific literature on Phellinus Linteus.

Related Experiment Videos

  • * Analysis of studies investigating PL's effects on immune function and inflammation.
  • * Examination of research on PL's anti-cancer properties, including apoptosis induction and synergy with chemotherapeutics.
  • * Brief overview of methods used for fractionation and identification of active compounds.

    • Main Results:

    • * Phellinus Linteus extracts stimulate both hormonal and cell-mediated immune responses.
    • * PL effectively suppresses tumor growth and metastasis.
    • * PL induces apoptosis in cancer cells without significant toxicity to normal cells.
    • * PL enhances the efficacy of certain conventional chemotherapeutic drugs.

    Conclusions:

    • * Phellinus Linteus is a promising candidate for alternative cancer therapy.
    • * PL exhibits potential as a synergistic agent to improve existing cancer treatments.
    • * Further research into PL's active components could lead to novel therapeutic strategies.